查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1662765

2030 年医药冷藏货柜市场预测：按产品类型、货柜尺寸、技术、运输方式、应用、最终用户和地区进行的全球分析

Reefer Container for Pharmaceutical Market Forecasts to 2030 - Global Analysis By Product Type, Container Size, Technology, Mode of Transport, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球医药冷藏货柜市场预计在 2024 年将达到 58.1 亿美元，到 2030 年将达到 103.6 亿美元，预测期内的复合年增长率为 10.1%。医药冷藏货柜是专门的冷藏运输货柜，旨在运输对温度敏感的医疗产品（例如疫苗、生技药品和某些药物）期间保持受控的温度环境。这些容器配备了先进的冷却系统，以确保产品保持在特定的温度范围内，以保持功效和安全性。冷藏货柜在低温运输物流中发挥着至关重要的作用，确保医药产品从生产设施到世界各地分销点的完整性。

生物製药需求不断成长

单株抗体、基因疗法和疫苗等生物製药需要严格的温度控制才能维持稳定性和功效。随着这些先进疗法变得越来越普遍，特别是在肿瘤学和慢性病管理领域，对可靠的低温运输物流的需求也日益增加。冷藏货柜对于运输这些易碎产品至关重要，可确保它们在运输过程中保持在所需的温度范围内。对生物製药日益增长的需求刺激了对温控运输解决方案的投资增加，并强调了有效低温运输管理的重要性。

温度波动的风险

胰岛素、生技药品和疫苗等对温度敏感的药物，只要稍微超出所需的温度范围，其品质和有效性就会受到威胁。运输过程中的温度不稳定可能由设备故障、隔热不足和外部环境等因素造成。这种风险凸显了先进的监控系统、定期维护和即时追踪以确保精确的温度控制的重要性。可靠的低温运输操作至关重要，因为任何温度完整性的丧失都可能导致昂贵的产品召回、品牌声誉受损和法律后果。

提高对低温运输物流的认识

提高对低温运输物流的认识是促进医药冷冻箱产业发展的重要因素。随着全球对疫苗、生技药品和其他生物来源製品等温度敏感药物的需求不断增加，在整个供应链中保持这些产品的完整性变得越来越重要。高效的低温运输管理有助于将温度敏感物品保持在指定范围内，从而避免产品劣化。冷藏货柜和温控运输选项的支出增加、更严格的监管以及消费者对更安全、更可靠药品的需求不断增长，都有助于提高供应链的效率和可靠性。

专用容器的可用性有限

製药业面临的一个障碍是专用冷冻货柜的供应有限，尤其是随着温控运输需求的增加。儘管许多冷藏货柜是作为通用物品製造的，但标准冷藏货柜可能无法满足医药产品高度专业化的温度和湿度要求。由于缺乏此类专用容器，导致供应链瓶颈、延误和额外成本，可能会阻碍医药物流的有效性。

COVID-19 的影响

新冠疫情大大促进了医药市场对冷藏货柜的需求。全球疫苗分发的迫切性，加上新冠疫苗和其他对温度敏感的药物对温度的严格要求，导致对可靠的低温运输物流的需求激增。这导致了对先进冷藏技术的投资增加、供应链弹性提高以及全球对确保温度敏感药品运输完整性的关注。

预计预测期内主动冷却系统部分将成为最大的部分。

由于需要精确和持续的温度控制来维持疫苗和生技药品等温度敏感产品的功效，主动冷却系统部门预计将在预测期内占据最大的市场占有率。主动冷却可确保运输过程中的稳定条件，尤其是在远距和波动的环境条件下。随着製药业对生物製药和全球分销的关注度日益提高，主动冷却系统对于满足严格的低温运输要求和监管标准至关重要。

预计预测期内物流供应商部门将以最高的复合年增长率成长。

由于对高效和温控运输解决方案的需求不断增长，预计物流供应商部门将在预测期内呈现最高的成长率。随着全球医药市场的成长，物流公司正在投资先进的低温运输技术，以满足疫苗和生技药品等温度敏感产品的严格要求。供应商在确保产品完整性、法规遵循和及时交付方面发挥着至关重要的作用，推动了医药物流对专用冷冻集装箱的需求。

比最大的地区

由于医疗保健、生物技术和製药领域的快速成长，预计亚太地区将在预测期内占据最大的市场占有率。疫苗和生技药品等温度敏感产品的需求不断增加，以及中国和印度等国家药品生产的扩大，都推动了对可靠的低温运输物流的需求。基础设施的不断完善和监管的不断推进进一步推动了全部区域温控运输解决方案的发展。

复合年增长率最高的地区

预计北美地区在预测期内将呈现最高的复合年增长率。这是因为该地区拥有强大的製药製造基础，并且对生技药品、疫苗和其他温度敏感药物的需求不断增加。 FDA 等严格的监管标准要求可靠的低温运输物流。此外，人们对生物製药、技术进步和强大分销网络的日益关注，进一步推动了对冷冻集装箱的需求，以保持整个供应链中的产品完整性。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场参与企业（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章全球医药冷藏货柜市场（依产品类型）

  • 介绍
  • 标准冷藏货柜
  • 气调冷藏货柜
  • 热电容器
  • 其他的

6. 全球医药冷藏货柜市场（依货柜尺寸）

  • 介绍
  • 20英尺
  • 40英尺
  • 高立方体

7. 全球医药冷藏货柜市场（按技术）

  • 介绍
  • 机械式冷冻系统
  • 主动冷却系统
  • 被动冷却系统

8. 全球医药冷藏货柜市场依运输方式划分

  • 介绍
  • 搭船
  • 路
  • 铁路

第九章全球医药冷藏货柜市场（按应用）

  • 介绍
  • 疫苗
  • 生物製药
  • 胰岛素和荷尔蒙
  • 临床试验数据
  • 电浆
  • 其他的

第 10 章全球医药冷藏货柜市场（按最终用户）

  • 介绍
  • 製药商
  • 物流供应商
  • 分销商/批发商
  • 其他的

第 11 章全球医药冷藏货柜市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司概况

  • Maersk Line
  • CMA CGM Group
  • MSC Mediterranean Shipping Company
  • Hapag-Lloyd
  • Evergreen Marine Corporation
  • AP Moller-Maersk
  • ZIM Integrated Shipping Services
  • Kuehne+Nagel
  • China COSCO Shipping Corporation
  • DP World
  • Seaco Global
  • DHL Supply Chain
  • United Arab Shipping Company（UASC）
  • Cool Containers
  • Geodis Logistics
Product Code: SMRC28626

According to Stratistics MRC, the Global Reefer Container for Pharmaceutical Market is accounted for $5.81 billion in 2024 and is expected to reach $10.36 billion by 2030 growing at a CAGR of 10.1% during the forecast period. A reefer container for pharmaceuticals is a specialized refrigerated shipping container designed to maintain a controlled temperature environment during the transportation of temperature-sensitive pharmaceutical products, such as vaccines, biologics, and certain medicines. These containers are equipped with advanced cooling systems to ensure that products remain within specific temperature ranges, preserving their efficacy and safety. Reefer containers play a critical role in cold-chain logistics, ensuring the integrity of pharmaceutical products from production facilities to distribution points across the world.

Market Dynamics:

Driver:

Rising demand for biopharmaceuticals

Biopharmaceutical products, such as monoclonal antibodies, gene therapies, and vaccines, require stringent temperature control to maintain their stability and efficacy. As these advanced therapies become more prevalent, especially in oncology and chronic disease management, the need for reliable cold chain logistics intensifies. Reefer containers are essential for transporting these sensitive products, ensuring that they remain within the required temperature range throughout their journey. This growing demand for biopharmaceuticals is fueling increased investments in temperature-controlled shipping solutions and reinforcing the importance of effective cold chain management.

Restraint:

Risk of temperature fluctuations

The quality and effectiveness of pharmaceutical products that are sensitive to temperature, such insulin, biologics, and vaccinations, can be jeopardized by even minor departures from the necessary temperature range. Temperature instability during transportation may be caused by elements such as equipment failure, insufficient insulation, or outside environmental circumstances. In order to guarantee accurate temperature management, this risk emphasizes the significance of sophisticated monitoring systems, routine maintenance, and real-time tracking. Reliable cold chain operations are crucial since any compromise in temperature integrity could lead to expensive product recalls, harm to a brand's reputation, and legal repercussions.

Opportunity:

Growing awareness of cold chain logistics

Growing knowledge of cold chain logistics is a major factor propelling the pharmaceutical reefer container industry. Maintaining the integrity of medicines across the supply chain is of greater importance as the demand for temperature-sensitive medications, such as vaccines, biologics, and other biologically derived products, rises globally. Product degradation is avoided by maintaining temperature-sensitive items within specified ranges thanks to efficient cold chain management. The supply chain's overall efficiency and dependability have increased as a result of increased expenditures in reefer containers and temperature-controlled shipping options, as well as tighter regulations and consumer demand for safer, more dependable pharmaceutical products.

Threat:

Limited availability of specialized containers

The pharmaceutical industry has a hurdle due to the restricted supply of specialized reefer containers, particularly as the need for temperature-controlled shipping grows. Standard refrigerated containers may not always be able to meet the highly specialized temperature and humidity requirements of pharmaceutical items, even though many reefer containers are made for universal usage. The effectiveness of pharmaceutical logistics might be hampered by supply chain bottlenecks, delays, and additional expenses caused by the lack of such specialized containers.

Covid-19 Impact

The COVID-19 pandemic significantly boosted the demand for reefer containers in the pharmaceutical market. The urgent need for global vaccine distribution, coupled with the stringent temperature requirements for COVID-19 vaccines and other temperature-sensitive pharmaceuticals, drove a surge in demand for reliable cold chain logistics. This led to increased investment in advanced reefer technologies, improved supply chain resilience, and a heightened focus on ensuring the integrity of temperature-sensitive pharmaceutical shipments worldwide.

The active cooling systems segment is expected to be the largest during the forecast period

The active cooling systems segment is expected to account for the largest market share during the forecast period, driven by the need for precise, continuous temperature control to maintain the efficacy of temperature-sensitive products like vaccines and biologics. Active cooling ensures stable conditions during transportation, especially over long distances or in fluctuating environmental conditions. As the pharmaceutical industry increasingly focuses on biopharmaceuticals and global distribution, active cooling systems are vital to meet stringent cold chain requirements and regulatory standards.

The logistics providers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the logistics providers segment is predicted to witness the highest growth rate, due to the rising demand for efficient, temperature-controlled transportation solutions. As the global pharmaceutical market grows, logistics companies are investing in advanced cold-chain technologies to meet the stringent requirements for temperature-sensitive products like vaccines and biologics. Providers play a critical role in ensuring product integrity, regulatory compliance, and timely delivery, driving the demand for specialized reefer containers in pharmaceutical logistics.

Region with largest share:

During the forecast period, Asia Pacific region is expected to hold the largest market share, due to rapid growth in healthcare, biotechnology, and pharmaceutical sectors. The increasing demand for temperature-sensitive products like vaccines and biologics, along with expanding pharmaceutical production in countries like China and India, has fueled the need for reliable cold-chain logistics. Enhanced infrastructure and regulatory developments further support the growth of temperature-controlled shipping solutions across the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to the region's strong pharmaceutical manufacturing base and growing demand for biologics, vaccines, and other temperature-sensitive drugs. Strict regulatory standards, such as those from the FDA, ensure the need for reliable cold chain logistics. Additionally, the increasing focus on biopharmaceuticals, advancements in technology, and robust distribution networks are further boosting the demand for reefer containers to maintain product integrity throughout the supply chain.

Key players in the market

Some of the key players profiled in the Reefer Container for Pharmaceutical Market include Maersk Line, CMA CGM Group, MSC Mediterranean Shipping Company, Hapag-Lloyd, Evergreen Marine Corporation, AP Moller-Maersk, ZIM Integrated Shipping Services, Kuehne + Nagel, China COSCO Shipping Corporation, DP World, Seaco Global, DHL Supply Chain, United Arab Shipping Company (UASC), Cool Containers, and Geodis Logistics.

Key Developments:

In September 2024, Maersk and Hapag-Lloyd announced their "Gemini Cooperation" to start in 2025 that would further improve the reliability of services and increase capacity by jointly operating a combined fleet of 290 vessels. It will underpin global trade routes, including those vital for pharmaceuticals.

In July 2024, MEDLOG, the logistics arm of MSC, has ceremoniously marked the start of construction of a 291,000 square foot state-of-the-art cold storage facility in Savannah, Georgia. The project is to symbolically signal a key addition to the export capability of poultry, pork and meat producers from the USA Southeast and Midwest.

Product Types Covered:

  • Standard Reefer Containers
  • Controlled-Atmosphere Reefer Containers
  • Thermoelectric Containers
  • Other Product Types

Container Sizes Covered:

  • 20 feet
  • 40 feet
  • High Cube

Technologies Covered:

  • Mechanical Refrigeration Systems
  • Active Cooling Systems
  • Passive Cooling Systems

Mode of Transports Covered:

  • Seaways
  • Roadways
  • Railways

Applications Covered:

  • Vaccines
  • Biopharmaceuticals
  • Insulin & Hormonal Drugs
  • Clinical Trial Material
  • Blood Plasma
  • Other Applications

End Users Covered:

  • Pharmaceutical Manufacturers
  • Logistics Providers
  • Distributors/Wholesalers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Reefer Container for Pharmaceutical Market, By Product Type

  • 5.1 Introduction
  • 5.2 Standard Reefer Containers
  • 5.3 Controlled-Atmosphere Reefer Containers
  • 5.4 Thermoelectric Containers
  • 5.5 Other Product Types

6 Global Reefer Container for Pharmaceutical Market, By Container Size

  • 6.1 Introduction
  • 6.2 20 feet
  • 6.3 40 feet
  • 6.4 High Cube

7 Global Reefer Container for Pharmaceutical Market, By Technology

  • 7.1 Introduction
  • 7.2 Mechanical Refrigeration Systems
  • 7.3 Active Cooling Systems
  • 7.4 Passive Cooling Systems

8 Global Reefer Container for Pharmaceutical Market, By Mode of Transport

  • 8.1 Introduction
  • 8.2 Seaways
  • 8.3 Roadways
  • 8.4 Railways

9 Global Reefer Container for Pharmaceutical Market, By Application

  • 9.1 Introduction
  • 9.2 Vaccines
  • 9.3 Biopharmaceuticals
  • 9.4 Insulin & Hormonal Drugs
  • 9.5 Clinical Trial Material
  • 9.6 Blood Plasma
  • 9.7 Other Applications

10 Global Reefer Container for Pharmaceutical Market, By End User

  • 10.1 Introduction
  • 10.2 Pharmaceutical Manufacturers
  • 10.3 Logistics Providers
  • 10.4 Distributors/Wholesalers
  • 10.5 Other End Users

11 Global Reefer Container for Pharmaceutical Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Maersk Line
  • 13.2 CMA CGM Group
  • 13.3 MSC Mediterranean Shipping Company
  • 13.4 Hapag-Lloyd
  • 13.5 Evergreen Marine Corporation
  • 13.6 AP Moller-Maersk
  • 13.7 ZIM Integrated Shipping Services
  • 13.8 Kuehne + Nagel
  • 13.9 China COSCO Shipping Corporation
  • 13.10 DP World
  • 13.11 Seaco Global
  • 13.12 DHL Supply Chain
  • 13.13 United Arab Shipping Company (UASC)
  • 13.14 Cool Containers
  • 13.15 Geodis Logistics

List of Tables

  • Table 1 Global Reefer Container for Pharmaceutical Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Reefer Container for Pharmaceutical Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Reefer Container for Pharmaceutical Market Outlook, By Standard Reefer Containers (2022-2030) ($MN)
  • Table 4 Global Reefer Container for Pharmaceutical Market Outlook, By Controlled-Atmosphere Reefer Containers (2022-2030) ($MN)
  • Table 5 Global Reefer Container for Pharmaceutical Market Outlook, By Thermoelectric Containers (2022-2030) ($MN)
  • Table 6 Global Reefer Container for Pharmaceutical Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 7 Global Reefer Container for Pharmaceutical Market Outlook, By Container Size (2022-2030) ($MN)
  • Table 8 Global Reefer Container for Pharmaceutical Market Outlook, By 20 feet (2022-2030) ($MN)
  • Table 9 Global Reefer Container for Pharmaceutical Market Outlook, By 40 feet (2022-2030) ($MN)
  • Table 10 Global Reefer Container for Pharmaceutical Market Outlook, By High Cube (2022-2030) ($MN)
  • Table 11 Global Reefer Container for Pharmaceutical Market Outlook, By Technology (2022-2030) ($MN)
  • Table 12 Global Reefer Container for Pharmaceutical Market Outlook, By Mechanical Refrigeration Systems (2022-2030) ($MN)
  • Table 13 Global Reefer Container for Pharmaceutical Market Outlook, By Active Cooling Systems (2022-2030) ($MN)
  • Table 14 Global Reefer Container for Pharmaceutical Market Outlook, By Passive Cooling Systems (2022-2030) ($MN)
  • Table 15 Global Reefer Container for Pharmaceutical Market Outlook, By Mode of Transport (2022-2030) ($MN)
  • Table 16 Global Reefer Container for Pharmaceutical Market Outlook, By Seaways (2022-2030) ($MN)
  • Table 17 Global Reefer Container for Pharmaceutical Market Outlook, By Roadways (2022-2030) ($MN)
  • Table 18 Global Reefer Container for Pharmaceutical Market Outlook, By Railways (2022-2030) ($MN)
  • Table 19 Global Reefer Container for Pharmaceutical Market Outlook, By Application (2022-2030) ($MN)
  • Table 20 Global Reefer Container for Pharmaceutical Market Outlook, By Vaccines (2022-2030) ($MN)
  • Table 21 Global Reefer Container for Pharmaceutical Market Outlook, By Biopharmaceuticals (2022-2030) ($MN)
  • Table 22 Global Reefer Container for Pharmaceutical Market Outlook, By Insulin & Hormonal Drugs (2022-2030) ($MN)
  • Table 23 Global Reefer Container for Pharmaceutical Market Outlook, By Clinical Trial Material (2022-2030) ($MN)
  • Table 24 Global Reefer Container for Pharmaceutical Market Outlook, By Blood Plasma (2022-2030) ($MN)
  • Table 25 Global Reefer Container for Pharmaceutical Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 26 Global Reefer Container for Pharmaceutical Market Outlook, By End User (2022-2030) ($MN)
  • Table 27 Global Reefer Container for Pharmaceutical Market Outlook, By Pharmaceutical Manufacturers (2022-2030) ($MN)
  • Table 28 Global Reefer Container for Pharmaceutical Market Outlook, By Logistics Providers (2022-2030) ($MN)
  • Table 29 Global Reefer Container for Pharmaceutical Market Outlook, By Distributors/Wholesalers (2022-2030) ($MN)
  • Table 30 Global Reefer Container for Pharmaceutical Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.